Valuation: Pfizer Inc

Market Cap 163B 144B 135B 123B 232B 15,651B 235B 1,633B 632B 7,971B 610B 597B 25,601B P/E 2026 *
18x
P/E 2027 * 13.9x
Enterprise Value 210B 187B 174B 159B 299B 20,223B 303B 2,111B 817B 10,299B 789B 771B 33,080B EV / Sales 2026 *
3.37x
EV / Sales 2027 * 3.41x
Free-Float
59.05%
Yield 2026 *
6.04%
Yield 2027 * 6.08%
Manager TitleAgeSince
Chief Executive Officer 64 01/01/2019
Director of Finance/CFO 55 16/08/2026
Compliance Officer 65 01/12/2013
Director TitleAgeSince
Director/Board Member 68 01/09/2007
Director/Board Member 62 27/09/2013
Chairman 64 01/01/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.54%-2.86%+39.10%+113.29% 1,031B
-1.84%-4.14%+39.46%+67.24% 638B
-0.35%-1.63%+6.71%+75.91% 462B
-1.07%-2.80%+59.59%+40.26% 359B
-0.03%-3.96%+23.63%+40.70% 335B
-1.58%-0.76%+13.50%+26.44% 273B
-2.02%-2.97%-3.25%+9.88% 253B
-2.27%+1.50%+38.07%+54.76% 228B
-0.65%-1.21%+33.04%+99.56% 185B
Average -1.19%-0.36%+27.76%+58.67% 418.21B
Weighted average by Cap. -1.07%-0.35%+30.70%+70.01%

Financials

2026 *2027 *
Net sales 62.24B 55.28B 51.69B 47.11B 88.69B 5,992B 89.91B 625B 242B 3,052B 234B 229B 9,802B 59.77B 53.08B 49.64B 45.24B 85.17B 5,754B 86.34B 601B 232B 2,931B 224B 220B 9,413B
Net income 8.9B 7.91B 7.39B 6.74B 12.68B 857B 12.86B 89.44B 34.62B 436B 33.42B 32.69B 1,402B 11.08B 9.84B 9.2B 8.39B 15.79B 1,067B 16.01B 111B 43.1B 543B 41.6B 40.7B 1,745B
Net Debt 47.48B 42.17B 39.44B 35.94B 67.66B 4,572B 68.59B 477B 185B 2,328B 178B 174B 7,478B 40.98B 36.4B 34.04B 31.02B 58.4B 3,946B 59.2B 412B 159B 2,009B 154B 151B 6,454B
Logo Pfizer Inc
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (42.9%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (28%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (26.9%); - other (2.2%). The United States accounts for 59.2% of net sales.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-